Education Cabinet Secretary Julius Migos Ogamba is set to release the first Kenya Junior School Education Assessment (KJSEA) ...

Vivo X300 Pro vs iPhone 17 Pro compared for performance, cameras, battery, pricing, and user needs to help buyers choose the best flagship ...

BISC is an ultra-thin neural implant that creates a high-bandwidth wireless link between the brain and computers. Its tiny single-chip design packs tens of thousands of electrodes and supports ...

In the phase 3 COBRA trial, researchers sought to compare the efficacy of KRd to VRd in newly diagnosed multiple myeloma patients regardless of cytogenic risk or transplant eligibility.

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Abbott said Thursday it would buy Exact Sciences, the maker of tests ...

Windows updates are notorious for introducing new problems, but rarely do they hit this hard. The latest Windows 11 patch has rendered “localhost” (the local loopback 127.0.0.1) completely ...

AMERICA’s BODY corporate looks, as a whole, to be in rude health. One large company after another is presenting record quarterly results. Bosses are raising profit forecasts left and right. Poke and ...

The healthcare diagnostics specialist posted its latest set of quarterly figures. This featured a surprise net profit, among other goodies. Just after market close on Monday, Exact Sciences took the ...

SINGAPORE – From Oct 11, visitors stepping into a hall at the Science Centre Singapore will be transported more than 400 million years into the past, when prehistoric creatures still roamed the planet ...

Wave Life Sciences (WVE) shares ended the last trading session 11.4% higher at $8.19. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.